Recent Quotes (30 days)

You have no recent quotes
chg | %

Dechra Pharmaceuticals plc news

   Watch this stock
Showing stories 1 - 10 of about 86   

Articles published

DPH 943.34 +4.84 (0.52%)
price chart
Are Genus plc And Dechra Pharmaceuticals plc Better Buys Than GlaxoSmithKline plc?
While shares in GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) have disappointed in the last year, it has not been the same story for a number of its pharmaceutical rivals. In fact, shares in Genus (LSE: GNS) and Dechra (LSE: DPH) have soared in the last 12 ...
Recent Analysts' Ratings Updates for Dechra Pharmaceuticals plc (DPH)
8/3/2015 - Dechra Pharmaceuticals plc had its “hold” rating reaffirmed by analysts at Numis Securities Ltd. They now have a GBX 978 ($15.30) price target on the stock.
Why I'd Buy GlaxoSmithKline plc Before Dechra Pharmaceuticals plc Or Al Noor ...
For investors in GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US), the last few years have been very challenging. That's because the company's bottom line has fallen by 17% during the last three years as sales have come under pressure from generic products ...
Dechra Pharmaceuticals plc (DPH) - Analysts' Weekly Ratings Changes
8/3/2015 - Dechra Pharmaceuticals plc had its “hold” rating reaffirmed by analysts at Numis Securities Ltd. They now have a GBX 978 ($15.14) price target on the stock.
Is AstraZeneca plc A Better Buy Than BTG plc, Dechra Pharmaceuticals plc And ...
Despite being in the midst of coming to terms with the loss of several key, blockbuster drugs, shares in AstraZeneca (LSE: AZN) (NYSE: AZN.
Dechra Pharmaceuticals plc Given Average Recommendation of "Buy" by Analysts ...
Dechra Pharmaceuticals plc logo Shares of Dechra Pharmaceuticals plc (LON:DPH) have received a consensus rating of “Buy” from the eight ratings firms that are presently covering the stock, MarketBeat reports.
Analysts' Recent Ratings Updates for Dechra Pharmaceuticals plc (DPH)
7/14/2015 - Dechra Pharmaceuticals plc had its “hold” rating reaffirmed by analysts at N+1 Singer. They now have a GBX 976 ($15.23) price target on the stock, up previously from GBX 927 ($14.47).
NAHL Group PLC Price Target Raised to GBX 375 (NAH)  Mideast Time
Dechra Pharmaceuticals plc (DPH) - Investment Analysts' Weekly Ratings Updates
8/3/2015 - Dechra Pharmaceuticals plc had its “hold” rating reaffirmed by analysts at Numis Securities Ltd. They now have a GBX 978 ($15.28) price target on the stock.
Dechra Pharmaceuticals plc Rating Reiterated by FinnCap (DPH)  WKRB News
Numis Securities Ltd Reiterates "Hold" Rating for Dechra Pharmaceuticals plc (DPH)
Dechra Pharmaceuticals plc logo Dechra Pharmaceuticals plc (LON:DPH)'s stock had its “hold” rating restated by analysts at Numis Securities Ltd in a report released on Monday, MarketBeat.
Dechra Pharmaceuticals plc's Buy Rating Reaffirmed at Jefferies Group (DPH)  WKRB News
Dechra Pharmaceuticals plc's Under Review Rating Reaffirmed at FinnCap (DPH)  sleekmoney
Dechra Pharmaceuticals plc (DPH) - Research Analysts' Weekly Ratings Changes
7/14/2015 - Dechra Pharmaceuticals plc had its “hold” rating reaffirmed by analysts at N+1 Singer. They now have a GBX 976 ($15.15) price target on the stock, up previously from GBX 927 ($14.39).